InvestorsHub Logo
Followers 20
Posts 689
Boards Moderated 0
Alias Born 08/28/2017

Re: None

Wednesday, 08/08/2018 1:06:25 AM

Wednesday, August 08, 2018 1:06:25 AM

Post# of 8305
With current results they may be discussing with FDA possible approval for short term use in acute PTSD exacerbations as it was effective at 4 weeks so maybe they can squeeze an FDA approval for "short term use in PTSD exacerbation" for patients its definitely better than nothing
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News